ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
-
ProPhase Labs to Present at the 2025 ThinkEquity Conference
-
Vivakor to Present at ThinkEquity Investor Conference on October 30, 2025
-
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
-
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
-
M-tron Industries, Inc. to Present at The ThinkEquity Conference on October 30, 2025
-
Pure Cycle Corporation to Present at the ThinkEquity Conference on October 30th
-
Beamr to Present at the ThinkEquity Conference
-
Devonian Health Group closes $334,500 private placement
-
Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units
-
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
-
5E Advanced Materials to Present at the ThinkEquity Conference in New York
-
CareCloud to Present at the 2025 ThinkEquity Conference
-
FG Nexus Initiates $200 Million Share Buyback Program
-
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
-
Alliance Entertainment to Present at the ThinkEquity Investor Conference
-
NioCorp to Participate in the 2025 Maxim Growth Summit in NYC on October 22-23, 2025
-
Avalon to Participate in ThinkEquity Conference
-
High Roller to Present at the 2025 ThinkEquity Conference
-
FibroBiologics to Present at the 2025 ThinkEquity Conference
-
Roadzen to Present at October Investor Conferences in New York
-
Tigo Energy to Participate in Multitude of Investor Conferences During the Fourth Quarter 2025
-
The Hottest Ticket in Town Will be Fireside at a VENU Amphitheater- 24/7 Market News
-
Journey Medical Corporation to Participate in October 2025 Investor Conferences
-
American Resources Corporation and ReElement Technologies Announce October Initial Slate of Conferences and Events
-
BitFuFu increases bitcoin holdings to 1,959 BTC in September
-
BitFuFu Announces September 2025 Bitcoin Production and Operation Updates: Bitcoin Holdings Increasing to 1,959 BTC
-
Vivani Medical withdraws Cortigent spin-off record date due to government shutdown
-
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
-
24/7 Market News: Analyst Upgrades amongst Flurry of Moves Venu Holdings Coverage
-
Resonance of Billions: 24/7 Market News Covers VENU’s Expanding Amphitheatre Empire
-
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
-
Sidus Space completes $9.8 million stock offering
-
Sidus Space Announces Closing of Public Offering
-
XTI Aerospace completes $20 million public offering
-
XTI Aerospace Announces Closing of $20 Million Public Offering
-
Sidus Space prices public offering at $1 per share for $9.8 million
-
Sidus Space Announces Pricing of Public Offering
-
Sidus Space plans public offering of Class A common stock
-
Sidus Space Announces Proposed Public Offering
-
XTI Aerospace prices $20 million public offering at $1.60 per share
-
XTI Aerospace Announces Pricing of $20 Million Public Offering
-
XTI Aerospace announces proposed public offering of stock and warrants
-
XTI Aerospace Announces Proposed Public Offering
-
WestPark Capital Announces the Hiring of Priyanka Mahajan as Managing Director of Investment Banking
-
Pelican Acquisition agrees to merge with Greenland energy firms
-
Pelican Acquisition Corporation (NASDAQ: PELI) Announces Definitive Merger Agreement with Greenland Exploration Limited and March GL Company, with the combined company to be named Greenland Energy Com
-
Origin Investment Corp I Announces that the Separate Trading of its Ordinary Shares and Warrants has Commenced
-
24/7 Market News: Everything’s Bigger in Texas… Especially the Sunset Amphitheaters (NYSE: VENU)
-
CEL-SCI completes $10 million stock offering for drug development

